Recruiting
Phase 1

Adoptive Cell Therapy

Sponsor:

AgonOx, Inc.

Code:

NCT05902520

Conditions

HNSCC

Melanoma

Gynecologic Cancer

Colorectal Cancer

Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DP CD8 TIL

DP CD8 TIL KD

Low dose IL-2

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information